Although NRP1 is weakly expressed on Tregs isolated from human blood and cannot be used as an identifying marker for circulating human Tregs, it has recently been shown that in humans, NRP1 is expressed on CD4+ tumor-inflitrating lymphocytes (TILs), including Tregs (141). This evidence concerns the gene NRP1 and neoplasm.